142 related articles for article (PubMed ID: 36938549)
1. CORRELATION OF EXPRESSION OF TGF- β AND MMP2 BETWEEN PROSTATIC ADENOCARCINOMA AND ADJACENT UNAFFECTED PARENCHYMA.
Mašić S; Bacalja J; Vučić M; Čupić H; Tomas D; Ulamec M; Spajić B; Skenderi F; Krušlin B
Acta Clin Croat; 2022 Oct; 61(Suppl 3):9-14. PubMed ID: 36938549
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
3. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
6. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
Tu H; Jacobs SC; Borkowski A; Kyprianou N
Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
[TBL] [Abstract][Full Text] [Related]
7. Prostatic ductal system in rats: tissue-specific expression and regional variation in stromal distribution of transforming growth factor-beta 1.
Nemeth JA; Sensibar JA; White RR; Zelner DJ; Kim IY; Lee C
Prostate; 1997 Sep; 33(1):64-71. PubMed ID: 9294629
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
Gabal SM; Habib FM; Helmy DO; Ibrahim MF
J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
[TBL] [Abstract][Full Text] [Related]
11. Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.
Li X; Placencio V; Iturregui JM; Uwamariya C; Sharif-Afshar AR; Koyama T; Hayward SW; Bhowmick NA
Oncogene; 2008 Nov; 27(56):7118-30. PubMed ID: 18724388
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta in benign and malignant prostate.
Lee C; Sintich SM; Mathews EP; Shah AH; Kundu SD; Perry KT; Cho JS; Ilio KY; Cronauer MV; Janulis L; Sensibar JA
Prostate; 1999 Jun; 39(4):285-90. PubMed ID: 10344218
[TBL] [Abstract][Full Text] [Related]
13. An immunocytochemical analysis of TGF alpha expression in benign and malignant prostatic tumors.
Harper ME; Goddard L; Glynne-Jones E; Wilson DW; Price-Thomas M; Peeling WB; Griffiths K
Prostate; 1993; 23(1):9-23. PubMed ID: 7687782
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta expression in prostate neoplasia.
Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-beta 1 in prostate cancer.
Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
[TBL] [Abstract][Full Text] [Related]
17. Dickkopf-3 regulates prostate epithelial cell acinar morphogenesis and prostate cancer cell invasion by limiting TGF-β-dependent activation of matrix metalloproteases.
Romero D; Al-Shareef Z; Gorroño-Etxebarria I; Atkins S; Turrell F; Chhetri J; Bengoa-Vergniory N; Zenzmaier C; Berger P; Waxman J; Kypta R
Carcinogenesis; 2016 Jan; 37(1):18-29. PubMed ID: 26503968
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.
Lovaas JD; Zhu L; Chiao CY; Byles V; Faller DV; Dai Y
Prostate; 2013 Apr; 73(5):522-30. PubMed ID: 23038275
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate.
Perry KT; Anthony CT; Steiner MS
Prostate; 1997 Oct; 33(2):133-40. PubMed ID: 9316654
[TBL] [Abstract][Full Text] [Related]
20. Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma.
Jia X; Sun Y; Wang B
IUBMB Life; 2014 Dec; 66(12):847-53. PubMed ID: 25631296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
